Skip to main content
Log in

Authors' reply: platelet aggregation inhibition with ticlopidine in the treatment of stroke

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski JW Harbison JW Panak E, Roberts RS, Sicurella J, Turpie AG (1989) The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1(8649):1215–20

    Article  CAS  PubMed  Google Scholar 

  2. Hass WK, Easton JD, Adams HP Jr., Pryse-Phillips W, Molony BA, Anderson S, Kamm B (1989) A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 321: 501–7

    Article  CAS  PubMed  Google Scholar 

  3. Treib J, Grauer MT, Woessner R, Morgenthaler (2000) Treatment of stroke on an intensive stroke unit: a novel concept. Intensive Care Med 26: 1598–1611

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Treib.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morgenthaler, M., Woessner, R., Grauer, M.T. et al. Authors' reply: platelet aggregation inhibition with ticlopidine in the treatment of stroke. Intensive Care Med 27, 621 (2001). https://doi.org/10.1007/s001340100861

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001340100861

Navigation